Cyclic vs Continuous Progesterone
Cyclic dosing mimics the natural luteal phase and produces predictable bleeding — preferred in perimenopause. Continuous dosing produces amenorrhea over time and is preferred in postmenopause.
Cyclic progesterone is the provider-reviewed default in perimenopause where ovarian activity persists.
Explore pathwayContinuous progesterone is the provider-reviewed default in postmenopause to achieve amenorrhea and steady symptom control.
Explore pathwayEducational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Will I still bleed on continuous?
Spotting can occur in the first 6–12 months, then typically resolves.
Can I switch?
Yes — provider review reassesses as phase progresses.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment